Evidence map›Paper›PMID 39054258›Full record

ArticleBrain and behavior2024

Underrecognition of migraine-related stigmatizing attitudes and social burden: Results of the OVERCOME Japan study.

Hisaka Igarashi, Mika Komori, Kaname Ueda, Anthony J Zagar, Dena H Jaffe, Yasuhiko Matsumori, Takao Takeshima, Koichi Hirata

Abstract read
In one paragraph

Article in Brain and behavior, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Observational
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hisaka IgarashiFujitsu Clinic, Kawasaki, Japan.
Mika KomoriJapan Drug Development and Medical Affairs, Eli Lilly Japan K.K., Kobe, Japan.ORCID 0000-0003-1887-1296
Kaname UedaJapan Drug Development and Medical Affairs, Eli Lilly Japan K.K., Kobe, Japan.
Anthony J ZagarReal World and Access Analytics, Eli Lilly and Company, Indianapolis, Indiana, USA.
Dena H JaffeReal World Evidence, Cerner Enviza, an Oracle Company (formerly Kantar Health), Jerusalem, Israel.ORCID 0000-0001-5134-037X
Yasuhiko MatsumoriSendai Headache and Neurology Clinic, Sendai, Japan.
Takao TakeshimaDepartment of Neurology, Headache Center, Tominaga Hospital, Osaka, Japan.
Koichi HirataDepartment of Neurology, Dokkyo Medical University, Mibu, Japan.

Funding

Eli Lilly and Company
6 · The paper itself

Abstract

introductionMigraine-related stigma (MiRS) and social burden is increasingly recognized. We assessed perspectives and attitudes toward migraine in people with and without migraine in Japan.

methodsOVERCOME (Japan) was a cross-sectional, population-based web survey of people with and without migraine (July-September 2020). People with migraine were individuals who met the modified International Classification of Headache Disorders criteria or had self-reported physician-diagnosed migraine. People without migraine were selected per quota sampling to represent the Japanese adult population. People with migraine reported their experiences on stigma and social burden and answered how frequently they experienced stigma using the MiRS questionnaire. Associations between MiRS and disability and MiRS and interictal burden were examined using the migraine disability assessment and Migraine Interictal Burden Scale-4. People without migraine reported their experiences and attitudes toward people with migraine by answering an 11-item attitudinal migraine questionnaire.

resultsA total of 17,071 and 2008 people with and without migraine, respectively, completed the survey. Overall, 11,228 (65.8%) respondents with migraine reported that they have never experienced stigma or burden; however, of the 12,383 employed respondents, 5841 (47.2%) reported that their current employers are not "extremely" or "very" understanding about their conditions. Moreover, ∼30%-40% of respondents "sometimes," "often," or "very often" hid their migraine from others. The proportion of respondents who experienced stigma often or very often, as assessed by MiRS, was 16.5%; this increased with the increasing number of monthly migraine headache days. The proportion of respondents with moderate-to-severe disability and interictal burden increased with increasing stigma. Among respondents without migraine, the proportion holding a stigmatizing attitude toward those with migraine was low (<15%); ∼80% had never experienced work- or family-related stigma or burden.

conclusionMiRS and burden exist but may be hidden and underrecognized in Japan. Disease awareness and education may be important to prevent and reduce stigma and burden.

Indexed as

Cost of IllnessMigraine DisordersSocial StigmaAdolescentAdultAgedCross-Sectional StudiesFemaleHealth Knowledge, Attitudes, PracticeHumansJapanMaleMiddle AgedStereotypingSurveys and QuestionnairesYoung Adultfree‐text termsJapanmesh termsmigraine disorderssocial burdensocial stigma

Identifiers

PMID39054258
PMCPMC11272416

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.